Anabolic effect of long-term estrogen replacement on bone collagen in elderly postmenopausal women with osteoporosis

Osteoporosis International

Volumn 12, Issue 6, 2001, Pages 465-470

  Khastgir, G ^a   Studd, J ^a   Holland, N ^a   Alaghband Zadeh, J ^b   Sims, T J ^c   Bailey, A J ^c  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Anabolic effect; Collagen; Crosslinks; Estrogen; Postmenopausal osteoporosis

Indexed keywords

COLLAGEN; ESTROGEN;

ADULT; AGED; ARTICLE; BONE MINERAL; CANCELLOUS BONE; CELL CULTURE; CELL STIMULATION; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CORTICAL BONE; CROSS LINKING; ESTROGEN THERAPY; FEMALE; HUMAN; OSSIFICATION; OSTEOBLAST; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN CONTENT; TENSILE STRENGTH;

AGED; AGED, 80 AND OVER; BONE AND BONES; BONE DENSITY; COLLAGEN; DENSITOMETRY, X-RAY; DRUG IMPLANTS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FEMUR; FOLLOW-UP STUDIES; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PELVIC BONES;

EID: 0034953814     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001980170091     Document Type: Article

References (31)

1. Collagen and disorders of bone
2. Biological significance of the cross-links of collagen
3. Collagen cross-links in mineralizing tissue: A review of their chemistry, function and clinical relevance
4. Maturation and ageing of collagen
5. Quantitative analysis of collagen and elastin cross-links using a single-column system
6. Collagen cross-linking in human bone and articular cartilage: Age related changes in the content of mature hydroxypyridinium residues
7. Age-related changes in the biochemical properties of human cancellous bone: Relationships to bone strength
8. Post-transitional modifications in the collagen of human osteoporotic femoral head
9. Reduced concentration of collagen reducible cross-links in human trabecular bone with respect to age and osteoporosis
10. The pathophysiology and treatment of postmenopausal osteoporosis. An evidence-based approach to oestrogen replacement therapy
11. Estrogen treatment of patients with established postmenopausal osteoporosis
12. Treatment of postmenopausal osteoporosis with transdermal estrogens
13. Enhanced osteoblastic proliferation and collagen gene expression by estradiol
14. 17β-Oestradiol stimulates cancellous bone formation in female rats
15. 17β-Estradiol stimulation of endosteal bone formation in the ovariectomised mouse: An animal model for the evaluation of bone-targeted estrogens
16. Effects on bone mass after eight years of hormonal replacement therapy
17. A randomised study on the effects of estragen/gestagen or high-dose oral calcium on trabecular bone remodelling in postmenopausal osteoporosis
18. The relationship between plasma oestradiol and increased bone density in postmenopausal women after treatment with subcutaneous hormone implants
19. The dose response of percutaneous oestradiol implants on the skeletons of postmenopausal women
20. Changes in collagen composition and cross-links in bone and skin of osteoporotic postmenopausal women treated with percutaneous estradiol implants
21. A cross-sectional study of the effects of long-term percutaneous hormone replacement therapy on bone density
22. The effect of long-term oestradiol implantation on bone mineral density in postmenopausal women who have undergone hysterectomy and bilateral oophorectomy
23. Normal and pathological remodelling of human trabecular bone: Three- dimensional reconstruction of the remodelling sequence in normal and in metabolic bone disease
24. Quantitative determination of collagen cross-links in extra-cellular matrix
25. Estimate of hydroxyproline by autoanalyser
26. The pathophysiology of peri- and postmenopausal bone loss
27. Changes in bone mineral density of the proximal femur and spine with aging: Difference between the postmenopausal and senile sundromes
28. Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women
29. Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss
30. Estrogen action on bone mass of postmenopausal women is dependent on body mass and initial bone density
31. Bone mineral density reflects bone mass but also the degree of mineralization of bone: Therapeutic implications